Mosapride
Alternative Names: AS 4370; Gasmotin; Mosafe; TAK 370Latest Information Update: 05 Nov 2023
At a glance
- Originator Dainippon Sumitomo Pharma
- Developer Eisai Co Ltd
- Class Antiulcers; Benzamides; Gastrokinetics; Morpholines; Small molecules
- Mechanism of Action Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Dyspepsia; Gastritis
- No development reported Non-ulcer dyspepsia
- Discontinued Gastro-oesophageal reflux; Gastrointestinal disorders